Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
7,442,329
-
Shares change
-
+931,232
-
Total reported value, excl. options
-
$66,697,000
-
Value change
-
+$8,406,975
-
Put/Call ratio
-
91%
-
Number of buys
-
28
-
Number of sells
-
11
-
Price
-
$8.97
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q2 2015
As of 30 Jun 2015 TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,442,329 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT CO, KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, venBio Select Advisor LLC, MILLENNIUM MANAGEMENT LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BLUESTEIN R H & CO, Lombard Odier Asset Management (USA) Corp, and MORGAN STANLEY.
This table shows 50 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.